Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model

By Bezard E.   Stutzmann J.-M.   Imbert C.   Boraud T.   Boireau A.   Gross C.E.  

European Journal of Pharmacology, Vol. 356, Iss. 2, 1998-09 ,pp. : 101-104

Elsevier

Access to resources Recommend Favorite

Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo

By Ferger B.   Spratt C.   Teismann P.   Seitz G.   Kuschinsky K.  

European Journal of Pharmacology, Vol. 360, Iss. 2, 1998-11 ,pp. : 155-163

Elsevier

Access to resources Recommend Favorite

Antagonism of apomorphine-induced spontaneous eyeblinks in the rhesus monkey: possible differences among the antipsychotics haloperidol, risperidone, and remoxipride

By Kleven M.S.   Koek W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 330-330

Elsevier

Access to resources Recommend Favorite

Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model

By Xu Bei-Bei   Liu Chun-Qing   Gao Xi   Zhang Wan-Qin   Wang Shi-Wei   Cao Ying-Lin  

Journal of Asian Natural Products Research, Vol. 7, Iss. 3, 2005-06 ,pp. : 215-224

Taylor & Francis Ltd

Access to resources Recommend Favorite

Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys

By Domino E.F.   Ni L.   Zhang H.   Kohno Y.   Sasa M.  

European Journal of Pharmacology, Vol. 325, Iss. 2, 1997-05 ,pp. : 137-144

Elsevier

Access to resources Recommend Favorite